Lifeward Ltd (NASDAQ:LFWD) Q1 Revenue Misses Estimates as Strategic Transformation Takes Shape
Lifeward Ltd. (LFWD) Q1 2026 Earnings Call Transcript
Lifeward Q1 2026 Earnings Call Transcript
HC Wainwright & Co. Maintains Buy on Lifeward, Raises Price Target to $10
Lifeward Ltd (LFWD) Q4 2025 Earnings Call Highlights: Strategic Moves and Market Challenges
Lifeward shares are trading lower after the company reported mixed Q4 financial results.
Lifeward: Q4 Earnings Snapshot
Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript
Lifeward Q4 Adj. EPS $(2.85) Misses $(1.08) Estimate, Sales $5.081M Miss $7.861M Estimate
Lifeward Ltd (LFWD) Q4 2025: Everything You Need To Know Ahead Of Earnings
Lifeward Regains Nasdaq Compliance
Lifeward shares are trading higher after the company announced a definitive agreement to acquire certain technology assets and related know-how prototypes from Skelable for $480,000 in equity.
Lifeward To Acquire Prototypes From Skelable For $480,000 In Equity.
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Lifeward shares are trading lower after the company announced a 1-for-12 reverse stock split.
Lifeward Announces Reverse Share Split
Lifeward Announces 1-For-12 Reverse Stock Split
Lifeward shares are trading higher after the company announced it has entered into a transformative strategic partnership with Oramed Pharmaceuticals. The company will issue $10 million in Senior Secured Convertible Notes in a private placement.
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.